Latest news
GlycoNex Doses First Patient in Phase I Trial of GNX1021, Advancing Its Glycan-Directed ADC into Clinical Development - PR NewswirePR Newswire · Mon, 03 Aug 2026 01:00:00 GMTIksuda Wins FDA IND Clearance for CA242-Directed ADC IKS04 in GI Cancers - BioPharm InternationalBioPharm International · Thu, 30 Jul 2026 16:19:27 GMTDr Tarantino on the Evolution of TROP2-Directed ADCs in First-Line TNBC - OncLiveOncLive · Wed, 29 Jul 2026 02:23:09 GMT